Monday, January 11, 2016
Cycle #14
Monday, January25, 2016
Cycle #15. Return for FOLFIRI treatment #15. Mike has not had bevacizumab the last few cycles due to oral ulceration of his gumline. The lower jaw incisors are somewhat eroded. Continue with cheotherapy at 30% dose reduction. Recent CEA improved to 54.8. Return in 2 weeks for cycle for cycle #16.
Monday, February 8, 2016
Cycle #16. Disease is stable. He is adequately palliated with minimal toxicity. Gumline is improved. Has follow up with his dentist 02/09/16. Received cycle #16 of FOLIRI, but continue to hold the Avastin. Reassess his CEA and scans again in March. Return in 2 weeks for further chemotherapy cycle #17.
Monday, February 8, 2016
Cycle #16. Disease is stable. He is adequately palliated with minimal toxicity. Gumline is improved. Has follow up with his dentist 02/09/16. Received cycle #16 of FOLIRI, but continue to hold the Avastin. Reassess his CEA and scans again in March. Return in 2 weeks for further chemotherapy cycle #17.
No comments:
Post a Comment